The much-awaited Amanta Healthcare IPO has opened for subscription, and investors are closely tracking its Grey Market Premium (GMP). Early trends in the grey market suggest a strong response, with the GMP reflecting a positive sentiment among retail and institutional investors

Amanta Healthcare IPO GMP Update

As of September 1, 2025, the Amanta Healthcare IPO GMP is trading around ₹28 per share, which translates to a 22% premium over the upper price band of ₹126. This indicates a likely listing price of ₹154 if current market enthusiasm continues

Digital International

Some platforms also report a slightly lower GMP of ₹25 (20% gain), while others show a conservative estimate of 15% premium. This variation is common as grey market movements change with investor demand and subscription status.

Subscription Status

Day 1 Response: Early subscription numbers suggest strong investor interest, with bids pouring in from both retail investors and qualified institutional buyers (QIBs).

Expected Trend: If demand continues at this pace, the issue is likely to be oversubscribed multiple times by closing day

What is Grey Market Premium (GMP)?

The Grey Market Premium is an unofficial market indicator where shares are traded before official listing. It shows the demand and expected listing price in advance

  • High GMP → Positive investor sentiment and potential listing gains
  • Low or Negative GMP → Weak demand or cautious outlook.

DIGI MERCH STORE PRINT ON DEMAND 

About Amanta Healthcare

Amanta Healthcare is a fast-growing pharmaceutical company with a strong presence in the healthcare sector. Its product portfolio includes IV fluids, injections, and critical care medicines. The company’s strong financials, expanding global reach, and robust distribution network make it an attractive choice for investors seeking exposure to the pharma sector.

Final Take

The Amanta Healthcare IPO GMP around 22% premium reflects strong investor sentiment. If momentum continues, the IPO may deliver double-digit listing gains. However, investors should remain cautious and consider both short-term opportunities and long-term fundamentals before making a decision


AmantaHealthcareIPOanalysis   WebGraphics

AmantaHealthcareIPOGMP           dailyprompt

AmantaHealthcareIPOreview      recipeidea

AmantaHealthcareIPOnews         SmartHome

AmantaHealthcareIPOapplyornot   Techtip

Comment


Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *